Related Experiment Video
Updated: Mar 29, 2026

Assessing Insulin Clearance in Mice via In Situ Liver Perfusion
Published on: December 13, 2024
Circulating Follistatin Is Liver-Derived and Regulated by the Glucagon-to-Insulin Ratio
Jakob S Hansen1, Sabine Rutti1, Caroline Arous1
1The Centre of Inflammation and Metabolism and the Centre for Physical Activity Research (J.S.H., B.K.P., P.P.), Rigshospitalet, University of Copenhagen, Denmark 2100; Department of Clinical Biochemistry (J.S.H., P.P.), Rigshospitalet, Copenhagen, Denmark 2100; Department of Genetic Medicine and Development (S.R., C.A., P.A.H., K.B.), University Medical Centre, University of Geneva, Geneva, Switzerland 1206; Department of Hepatology (J.O.C.), Rigshospitalet, Copenhagen, Denmark 2100; Department of Anaesthesiology (N.H.S.), The Copenhagen Muscle Research Centre, Rigshospitalet, Copenhagen, Denmark 2100; Division of Pathobiochemistry and Clinical Chemistry (A.D., C.W.), Department of Internal Medicine IV, University Tuebingen, Germany 72076; University Hospitals of Geneva (C.G.-G.), Surgical Research Unit, Geneva, Switzerland 1206; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München (C.W.), University of Tuebingen, Tuebingen, Germany 72076; German Center for Diabetes Research (C.W.), München-Neuherberg, Germany 85764.
Context:
Follistatin is a plasma protein recently reported to increase under conditions with negative energy balance, such as exercise and fasting in humans. Currently, the perception is that circulating follistatin is a result of para/autocrine actions from various tissues. The large and acute increase in circulating follistatin in response to exercise suggests that it may function as an endocrine signal.
Objective:
We assessed origin and regulation of circulating follistatin in humans.
Design/Interventions:
First, we assessed arterial-to-venous difference of follistatin over the splanchnic bed at rest and during exercise in healthy humans. To evaluate the regulation of plasma follistatin we manipulated glucagon-to-insulin ratio in humans at rest as well as in cultured hepatocytes. Finally, the impact of follistatin on human islets of Langerhans was assessed.
Results:
We demonstrate that in humans the liver is a major contributor to circulating follistatin both at rest and during exercise. Glucagon increases and insulin inhibits follistatin secretion both in vivo and in vitro, mediated via the secondary messenger cAMP in the hepatocyte. Short-term follistatin treatment reduced glucagon secretion from islets of Langerhans, whereas long-term follistatin treatment prevented apoptosis and induced proliferation of rat β cells.
Conclusions:
In conclusion, in humans, the liver secretes follistatin at rest and during exercise, and the glucagon-to-insulin ratio is a key determinant of circulating follistatin levels. Circulating follistatin may be a marker of the glucagon-to-insulin tone on the liver.
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin: The Receptor and Signaling Pathways
Feedback Loops
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

